How long before Wegovy suppresses appetite — and what actually happens first

The myth that appetite vanishes on day one

The most common misconception people bring to this question is that Wegovy works like a light switch, one injection and hunger disappears. It is easy to see why that idea takes hold; some accounts online do describe a dramatic first-week effect. But for most people starting at the 0.25mg dose, the experience is far quieter than that, and expecting an overnight transformation can lead to unnecessary disappointment.

What the starting dose is actually doing is giving your body time to adjust to semaglutide before the levels that genuinely move appetite are reached. The GLP-1 receptor pathway that Wegovy acts on (slowing gastric emptying and influencing the brain's satiety signals) needs therapeutic concentrations to produce a consistent effect, and those concentrations build across the titration schedule. Letting go of the day-one expectation is not a reason to doubt the medicine; it is a reason to give it the weeks it is designed to need.

The speed of appetite suppression on Wegovy varies between individuals, but the clinical picture is consistent: gradual onset, building with each dose step. If you are wondering how long Wegovy takes to reduce appetite in practice, that pattern is worth understanding before the first pen arrives.

What tends to happen across the titration period

Wegovy's licensed schedule moves through 0.25mg, 0.5mg, 1.0mg, 1.7mg and 2.4mg, each step held for roughly four weeks under a prescriber's guidance. Many people describe the first noticeable shift in appetite somewhere around weeks two to four, often as a change in portion size rather than a loss of interest in food altogether. Meals feel satisfying sooner. The urge to snack between meals softens. These are early signals that the medicine is working as intended.

The step from 1.0mg to 1.7mg and then to 2.4mg is where most people report a more pronounced effect. By the time the 2.4mg maintenance dose is established (typically around week 17 to 20 from starting) appetite suppression is usually at its most consistent. The relationship between semaglutide dose and appetite suppression is broadly dose-dependent, which is why titration exists rather than starting at the top.

It is also worth noting that semaglutide's half-life means levels accumulate between doses, by week four at any given dose, blood concentrations are steadier than after the first injection at that level. So the effect at week four of a dose step is meaningfully different from week one of it. Patience across the full titration is not passive waiting; it is how the medicine works.

For context on how this timeline connects to actual weight reduction, the broader question of how long Wegovy takes to work covers what clinical trials found across the full treatment period.

Why appetite and weight loss can feel out of step, and when to raise concerns

Some people lose weight during the early weeks before they feel much appetite change. Others notice a clear drop in hunger but find the scale slower to move. Both experiences are normal. Weight change reflects energy balance across days and weeks; appetite suppression influences it but is not the only variable. Sleep, activity, what is being eaten alongside treatment, and individual metabolic differences all play into the pace of change.

The STEP 1 trial, published in the New England Journal of Medicine, found an average weight reduction of around 15% over 68 weeks at the 2.4mg dose, a figure that reflects the full titration period and sustained maintenance, not a sprint from week one. Understanding that arc makes the early weeks feel less like stalling and more like the foundation being laid.

If, by around week eight to twelve, there is genuinely no sense of appetite change at all alongside the early doses, that is worth discussing with the prescribing team rather than pushing quietly through. The same applies to side effects: nausea, constipation and digestive discomfort are common during titration, per NHS guidance on semaglutide, and usually settle, but ongoing or severe symptoms deserve clinical input, not tolerance. There is a fuller picture of the early adjustment period in the guide to Wegovy's appetite-curbing timeline.

For anyone thinking about what treatment costs alongside whether it is clinically right for them, the Wegovy price comparison page sets out what a private prescription typically includes in the UK. The clinical question and the cost question are separate; it is worth looking at both before deciding. If you are ready to explore whether Wegovy is suitable for you, our prescribers are available seven days a week, start a free consultation and a named clinician will review your answers the same day.